Damia Tormo

Damia Tormo has a diverse range of work experience in the biotechnology and venture capital industries. They are currently working as a Director at both Integra Therapeutics and Minoryx Therapeutics, starting in 2022. In 2021, they founded and served as Director at Tyris tx, an innovative platform that develops advanced genetic treatments for rare diseases. They also held the position of Director at Aleta Biotherapeutics Inc and founder and Director at Syngoi Therapeutics in 2021. Prior to this, Damia Tormo was the General Partner at COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A, a venture capital management company focused on medical solutions. They also served on the Board of Directors at ALGENEX S.L and held the positions of Director & Founder and CEO & Co-founder at Artax Biopharma Inc. Additionally, Damia Tormo has experience as the President & Member Board of Trustees at Fundación Columbus, and as a Founder at Radioterapia de Protones (Quirón) in 2017.

Damia Tormo's education history begins in 1999 when they earned a Master of Science (MS) degree in Biology from the University of Valencia. They then pursued a Bachelor of Science (BS) degree in Biological Sciences from Bonn-Rhein-Sieg University of Applied Sciences from 2003 to 2004.

Continuing their education, Tormo obtained a PhD in Molecular Genetics and Immunology from the University of Bonn, graduating between 2004 and 2007. In 2010, they participated in a course for Biotech Executives at Genoma España, focusing on Biotech Management.

During 2009 and 2010, Tormo attended IE Business School, earning a Master's degree in Biotechnology Management. The following year, in 2011, Tormo pursued an additional program at the University of Cambridge, more specifically at the Judge Business School, CfEL, Centre for Entrepreneurial Learning, specializing in Entrepreneurship.

Based on this chronological information, Damia Tormo's education path reflects a strong focus on biology, genetics, immunology, and biotechnology, while also exploring aspects of management and entrepreneurship.